Monte Rosa Therapeutics Inks Strategic Collaboration With Roche To Develop Molecular Glue Degraders

Roche To Invest $50 Bln In U.S; To Create 12,000 Jobs

Amid the ongoing tariff issues, Swiss drug major Roche Holding AG announced its plan to invest $50 billion in the United States in the next five years, aiming to expand its Pharmaceutical and Diagnostics Divisions. With all new and expanded manufacturing capacity, Roche aims to export more medicines from the US than it imports.

RTTNews | 22天前

Roche Q1 Sales Down, Confirms FY24 View; Stock Down

Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

RTTNews | 385天前

It's A First; Cellular Therapy For Melanoma And Drug To Reduce Food Allergic Reactions Get FDA Nod

Latest approvals by the U.S. Food and Drug Administration include Iovance Biotherapeutics Inc.'s Amtagvi - the first cellular therapy indicated for the treatment of unresectable or metastatic melanoma, as well as Genentech's Xolair- the first medication to help reduce allergic reactions to multiple foods after accidental exposure.

RTTNews | 449天前

ShapeTX Expands Ongoing Collaboration With Roche

ShapeTX announced Thursday the expansion of its partnership with Roche Holding AG (RHHBY.PK), with Roche adding a new target to their ongoing collaboration, which was initially established in August 2021.

RTTNews | 531天前

Genentech Announces New Data From Phase II FENopta Study Of Fenebrutinib For People With RMS

Genentech, Inc., a subsidiary of the Roche Group (RHHBY.PK) announced Friday new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS). The data has a consistent safety profile to other fenebrutinib trials.

RTTNews | 579天前

Roche Says FDA Clears Additional Alzheimer's Disease Cerebrospinal Fluid Assays

Swiss drug major Roche Holding AG (RHHBY) announced Tuesday that its Elecsys beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys Total-Tau CSF assays (tTau) have received U.S. Food and Drug Administration (FDA) 510(k) clearance.

RTTNews | 687天前

SD Biosensor Recalls Certain COVID-19 At-Home Tests Distributed By Roche

Seoul, South Korea -based SD Biosensor, Inc. has recalled specific Pilot COVID-19 At-Home Tests, distributed by Roche Diagnostics in the United States, citing potential microbial contamination in the liquid buffer solution, the U.S. Food and Drug Administration said. The Pilot COVID-19 At-Home Test is an over-the-counter rapid antigen test and uses a nasal swab sample that can be self-collected...

RTTNews | 737天前

Pound Falls Against U.S. Dollar, Euro

The pound dropped against the U.S. dollar and the euro in the New York session on Wednesday.

RTTNews | 10分钟前

EURUSD	1.11713	GBPUSD	1.32573	AUDUSD	0.64243
USDJPY	146.818	USDCAD	1.39766	USDCHF	0.84314

Advertisement

Monte Rosa Therapeutics Inks Strategic Collaboration With Roche To Develop Molecular Glue Degraders